Regeneus
(ASX:RGS)
Overview
Regeneus Ltd (ASX: RGS) is an Australian clinical-stage regenerative medicine company developing a portfolio of innovative cellular therapies targeting significant unmet medical needs with a licence driven strategy.
Our Latest Articles on Regeneus
| Type | Date | Title |
|---|---|---|
| Article | 02-Mar-2020 | Can This ASX Junior Surge Through the Pain Barrier? |
Market Data
Latest Article
Can This ASX Junior Surge Through the Pain Barrier?
Mar 2, 2020
Biotech company Regeneus (ASX:RGS) is a regenerative medicine company, and the therapy is a novel stem cell therapy.
